Surprise! Pfizer And Lilly File Tanezumab For Pain With FDA Despite Safety Questions

 
• By Jessica Merrill
Surprise confetti
The prospects for tanezumab are uncertain • Source: Shutterstock

More from Neurological

More from Therapy Areas